|
|
||||||||




Departments of
*
Cell Processing and
Clinical Immunology and AIDS Research Center, Institute of Medical Science, University of Tokyo, Tokyo, Japan; and
Japanese Red Cross Central Blood Center, Tokyo, Japan
We examined the effect of TGF-ß1 on the chemotactic migratory
ability of human monocyte-derived dendritic cells (DCs). Treatment of
immature DCs with TGF-ß1 resulted in increased expressions of CCR-1,
CCR-3, CCR-5, CCR-6, and CXC chemokine receptor-4 (CXCR-4), which were
concomitant with enhanced chemotactic migratory responses to their
ligands, RANTES (for CCR-1, CCR-3, and CCR-5), macrophage-inflammatory
protein-3
(MIP-3
) (for CCR-6), or stromal cell-derived growth
factor-1
(for CXCR-4). Ligation by TNF-
resulted in
down-modulation of cell surface expressions of CCR-1, CCR-3, CCR-5,
CCR-6, and CXCR-4, and the chemotaxis for RANTES, MIP-3
, and stromal
cell-derived growth factor-1
, whereas this stimulation up-regulated
the expression of CCR-7 and the chemotactic ability for MIP-3ß.
Stimulation of mature DCs with TGF-ß1 also enhanced TNF-
-induced
down-regulation of the expressions of CCR-1, CCR-3, CCR-5, CCR-6, and
CXCR-4, and chemotaxis to their respective ligands, while this
stimulation suppressed TNF-
-induced expression of CCR-7 and
chemotactic migratory ability to MIP-3ß. Our findings suggest that
TGF-ß1 reversibly regulates chemotaxis of DCs via regulation of
chemokine receptor expression.
This article has been cited by other articles:
![]() |
C. Happel, A. D. Steele, M. J. Finley, M. A. Kutzler, and T. J. Rogers DAMGO-induced expression of chemokines and chemokine receptors: the role of TGF-{beta}1 J. Leukoc. Biol., April 1, 2008; 83(4): 956 - 963. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Qi, X. Chen, Y. Zhang, J. Holian, E. Mreich, R. E. Gilbert, D. J. Kelly, and C. A. Pollock High glucose induces macrophage inflammatory protein-3{alpha} in renal proximal tubule cells via a transforming growth factor-{beta}1 dependent mechanism Nephrol. Dial. Transplant., November 1, 2007; 22(11): 3147 - 3153. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Bertram, S. Baltic, N. L. Misso, K. D. Bhoola, P. S. Foster, P. J. Thompson, and M. Fogel-Petrovic Expression of kinin B1 and B2 receptors in immature, monocyte-derived dendritic cells and bradykinin-mediated increase in intracellular Ca2+ and cell migration J. Leukoc. Biol., June 1, 2007; 81(6): 1445 - 1454. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Nemunaitis, R. O. Dillman, P. O. Schwarzenberger, N. Senzer, C. Cunningham, J. Cutler, A. Tong, P. Kumar, B. Pappen, C. Hamilton, et al. Phase II Study of Belagenpumatucel-L, a Transforming Growth Factor Beta-2 Antisense Gene-Modified Allogeneic Tumor Cell Vaccine in Non-Small-Cell Lung Cancer J. Clin. Oncol., October 10, 2006; 24(29): 4721 - 4730. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bobik Transforming Growth Factor-{beta}s and Vascular Disorders Arterioscler. Thromb. Vasc. Biol., August 1, 2006; 26(8): 1712 - 1720. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. von Bergwelt-Baildon, A. Popov, T. Saric, J. Chemnitz, S. Classen, M. S. Stoffel, F. Fiore, U. Roth, M. Beyer, S. Debey, et al. CD25 and indoleamine 2,3-dioxygenase are up-regulated by prostaglandin E2 and expressed by tumor-associated dendritic cells in vivo: additional mechanisms of T-cell inhibition Blood, July 1, 2006; 108(1): 228 - 237. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Guriec, C. Daniel, K. Le Ster, E. Hardy, and C. Berthou Cytokine-regulated expression and inhibitory function of Fc{gamma}RIIB1 and -B2 receptors in human dendritic cells J. Leukoc. Biol., January 1, 2006; 79(1): 59 - 70. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Basu and H. E. Broxmeyer Transforming growth factor-{beta}1 modulates responses of CD34+ cord blood cells to stromal cell-derived factor-1/CXCL12 Blood, July 15, 2005; 106(2): 485 - 493. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. S. Jones, S. Akel, C. Petrow-Sadowski, Y. Huang, D. C. Bertolette, and F. W. Ruscetti Induction of Human T Cell Leukemia Virus Type I Receptors on Quiescent Naive T Lymphocytes by TGF-{beta} J. Immunol., April 1, 2005; 174(7): 4262 - 4270. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. Stenmark, N. J. Davie, J. T. Reeves, and M. G. Frid Hypoxia, leukocytes, and the pulmonary circulation J Appl Physiol, February 1, 2005; 98(2): 715 - 721. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Crane-Godreau and C. R. Wira CCL20/Macrophage Inflammatory Protein 3{alpha} and Tumor Necrosis Factor Alpha Production by Primary Uterine Epithelial Cells in Response to Treatment with Lipopolysaccharide or Pam3Cys Infect. Immun., January 1, 2005; 73(1): 476 - 484. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Choudhary, N. R. Choudhary, K. C. Kimbrell, J. Colasanti, A. Ziogas, D. Kwa, H. Schuitemaker, and D. Camerini R5 Human Immunodeficiency Virus Type 1 Infection of Fetal Thymic Organ Culture Induces Cytokine and CCR5 Expression J. Virol., January 1, 2005; 79(1): 458 - 471. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Sela, R. Hershkoviz, L. Cahalon, O. Lider, and E. Mozes Down-Regulation of Stromal Cell-Derived Factor-1{alpha}-Induced T Cell Chemotaxis by a Peptide Based on the Complementarity-Determining Region 1 of an Anti-DNA Autoantibody via Up-Regulation of TGF-{beta} Secretion J. Immunol., January 1, 2005; 174(1): 302 - 309. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Kelly, Y. Zhang, R. Gow, and R. E. Gilbert Tranilast Attenuates Structural and Functional Aspects of Renal Injury in the Remnant Kidney Model J. Am. Soc. Nephrol., October 1, 2004; 15(10): 2619 - 2629. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. C. Roy, G. Bandyopadhyay, S. Rakshit, M. Ray, and S. Bandyopadhyay IL-4 alone without the involvement of GM-CSF transforms human peripheral blood monocytes to a CD1adim, CD83+ myeloid dendritic cell subset J. Cell Sci., July 15, 2004; 117(16): 3435 - 3445. [Abstract] [Full Text] [PDF] |
||||
![]() |
R Nissinen, M Leirisalo-Repo, R Peltomaa, T Palosuo, and O Vaarala Cytokine and chemokine receptor profile of peripheral blood mononuclear cells during treatment with infliximab in patients with active rheumatoid arthritis Ann Rheum Dis, June 1, 2004; 63(6): 681 - 687. [Abstract] [Full Text] |
||||
![]() |
M. A. Crane-Godreau and C. R. Wira Effect of Escherichia coli and Lactobacillus rhamnosus on Macrophage Inflammatory Protein 3{alpha}, Tumor Necrosis Factor Alpha, and Transforming Growth Factor {beta} Release by Polarized Rat Uterine Epithelial Cells in Culture Infect. Immun., April 1, 2004; 72(4): 1866 - 1873. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Karsdal, P. Hjorth, K. Henriksen, T. Kirkegaard, K. L. Nielsen, H. Lou, J.-M. Delaisse, and N. T. Foged Transforming Growth Factor-{beta} Controls Human Osteoclastogenesis through the p38 MAPK and Regulation of RANK Expression J. Biol. Chem., November 7, 2003; 278(45): 44975 - 44987. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-C. Farges, A. Romeas, M. Melin, J.-J. Pin, S. Lebecque, M. Lucchini, F. Bleicher, and H. Magloire TGF-{beta}1 Induces Accumulation of Dendritic Cells in the Odontoblast Layer J. Dent. Res., August 1, 2003; 82(8): 652 - 656. [Abstract] [Full Text] |
||||
![]() |
R. Dong, K. Cwynarski, A. Entwistle, F. Marelli-Berg, F. Dazzi, E. Simpson, J. M. Goldman, J. V. Melo, R. I. Lechler, I. Bellantuono, et al. Dendritic cells from CML patients have altered actin organization, reduced antigen processing, and impaired migration Blood, May 1, 2003; 101(9): 3560 - 3567. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Kobie, R. S. Wu, R. A. Kurt, S. Lou, M. K. Adelman, L. J. Whitesell, L. V. Ramanathapuram, C. L. Arteaga, and E. T. Akporiaye Transforming Growth Factor {beta} Inhibits the Antigen-Presenting Functions and Antitumor Activity of Dendritic Cell Vaccines Cancer Res., April 15, 2003; 63(8): 1860 - 1864. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Woltman and C. van Kooten Functional modulation of dendritic cells to suppress adaptive immune responses J. Leukoc. Biol., April 1, 2003; 73(4): 428 - 441. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Y. Kao, Y. Gong, C.-M. Chen, Q.-D. Zheng, and J.-J. Chen Tumor-Derived TGF-{beta} Reduces the Efficacy of Dendritic Cell/Tumor Fusion Vaccine J. Immunol., April 1, 2003; 170(7): 3806 - 3811. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Ahn, Y. Lee, C. Jeon, S.-J. Lee, B.-H. Lee, K. D. Choi, and Y.-S. Bae Identification of the genes differentially expressed in human dendritic cell subsets by cDNA subtraction and microarray analysis Blood, August 13, 2002; 100(5): 1742 - 1754. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Sato, H. Kawasaki, C. Morimoto, N. Yamashima, and T. Matsuyama An Abortive Ligand-Induced Activation of CCR1-Mediated Downstream Signaling Event and a Deficiency of CCR5 Expression Are Associated with the Hyporesponsiveness of Human Naive CD4+ T Cells to CCL3 and CCL5 J. Immunol., June 15, 2002; 168(12): 6263 - 6272. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. DORFMULLER, V. ZARKA, I. DURAND-GASSELIN, G. MONTI, K. BALABANIAN, G. GARCIA, F. CAPRON, A. COULOMB-LHERMINE, A. MARFAING-KOKA, G. SIMONNEAU, et al. Chemokine RANTES in Severe Pulmonary Arterial Hypertension Am. J. Respir. Crit. Care Med., February 15, 2002; 165(4): 534 - 539. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-C. Dieu-Nosjean, C. Massacrier, B. Vanbervliet, W.-H. Fridman, and C. Caux IL-10 Induces CCR6 Expression During Langerhans Cell Development While IL-4 and IFN-{gamma} Suppress It J. Immunol., November 15, 2001; 167(10): 5594 - 5602. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Parlato, S. M. Santini, C. Lapenta, T. Di Pucchio, M. Logozzi, M. Spada, A. M. Giammarioli, W. Malorni, S. Fais, and F. Belardelli Expression of CCR-7, MIP-3beta , and Th-1 chemokines in type I IFN-induced monocyte-derived dendritic cells: importance for the rapid acquisition of potent migratory and functional activities Blood, November 15, 2001; 98(10): 3022 - 3029. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Takayama, A. E. Morelli, N. Onai, M. Hirao, K. Matsushima, H. Tahara, and A. W. Thomson Mammalian and Viral IL-10 Enhance C-C Chemokine Receptor 5 but Down-Regulate C-C Chemokine Receptor 7 Expression by Myeloid Dendritic Cells: Impact on Chemotactic Responses and In Vivo Homing Ability J. Immunol., June 15, 2001; 166(12): 7136 - 7143. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. G. Vaday, S. Franitza, H. Schor, I. Hecht, A. Brill, L. Cahalon, R. Hershkoviz, and O. Lider Combinatorial signals by inflammatory cytokines and chemokines mediate leukocyte interactions with extracellular matrix J. Leukoc. Biol., June 1, 2001; 69(6): 885 - 892. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Caron, Y. Delneste, E. Roelandts, C. Duez, N. Herbault, G. Magistrelli, J.-Y. Bonnefoy, J. Pestel, and P. Jeannin Histamine Induces CD86 Expression and Chemokine Production by Human Immature Dendritic Cells J. Immunol., May 15, 2001; 166(10): 6000 - 6006. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Sato, H. Kawasaki, H. Nagayama, M. Enomoto, C. Morimoto, K. Tadokoro, T. Juji, and T. A. Takahashi Signaling events following chemokine receptor ligation in human dendritic cells at different developmental stages Int. Immunol., February 1, 2001; 13(2): 167 - 179. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Sato, H. Kawasaki, H. Nagayama, M. Enomoto, C. Morimoto, K. Tadokoro, T. Juji, and T. A. Takahashi Chemokine Receptor Expressions and Responsiveness of Cord Blood T Cells J. Immunol., February 1, 2001; 166(3): 1659 - 1666. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |